Clinical trial · Observational
Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Background.Although the life expectancy of patients with FL has recently increased, notably since the introduction of rituximab in combination with chemotherapy, little is known regarding the precise causes of patients death. Patients and methods'. This study describes the different causes of death in FL patients among followed since 2000 at Lyon University Hospital, centre Léon Bérard and Mayo Clinic. The causes of death will be classified as related to lymphoma progression, treatment-related toxicity (including TRM and secondary myelodysplastic syndrome/acute myeloid leukemia), secondary neoplasias, or other.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| This Study Describes the Different Causes of Death in 237 FL Patients | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (4)
- label
- LP: Lymphoma Progression
- label
- TRM: Treatment Related Mortality
- label
- NHM: Non hematologic malignancy
- label
- OC: Other Cause
Primary outcomes (1)
- measure
- overall survival (OS)
- timeFrame
- OS length was calculated from the date of diagnosis to the date of death
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * FL patients * patients recorded as deceased Exclusion Criteria: -Other diagnosis than FL
References
Publications (0)
Data not yet available